This document is a publication of a patent application, specifically US20260085092A1, filed by Zeng Xin Dong and Jacques-Pierre Moreau. The application describes compounds that act as ligands for melanocortin receptors, along with their pharmaceutically acceptable salts, methods of use for treating mammals, and pharmaceutical compositions containing these compounds. The filing date was April 28, 2025.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future intellectual property developments in the area of melanocortin receptor ligands, which may be of interest to pharmaceutical and drug development companies for competitive intelligence and R&D planning.